Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 3

Gastrointestinal stromal tumors

Malign gastrointestinal stromal tümörler

Pages
295–300
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Univariate analyses revealed that only tumors confined to the site of origin at presentation resulted in prolonged overall survival (p=0.01).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gastrointestinal stromal tumors are a rare group of tumors of the alimentary tract originating mainly from the mesenchymal tissues of the wall of hollow viscera.
📊
Key Findings & Data:Material and Methods: Patients treated with a malignant gastrointestinal stromal tumor between 1995-2001 were reviewed retrospectively.
💡
Conclusion & Impact:Univariate analyses revealed that only tumors confined to the site of origin at presentation resulted in prolonged overall survival (p=0.01).
🔬Design:Review & Systematic Survey
📍Scope:2001 Verileri
⚙️Variables:Geriyedönük çalışma · Seyir · Gastrointestinal neoplazmlar

Abstract

Objective: Gastrointestinal stromal tumors are a rare group of tumors of the alimentary tract originating mainly from the mesenchymal tissues of the wall of hollow viscera. The current study aimed to review the clinicopathologic parameters affecting the prognosis in a group of patients with malignant gastrointestinal stromal tumors. Material and Methods: Patients treated with a malignant gastrointestinal stromal tumor between 1995-2001 were reviewed retrospectively. Histologic sections were stained with hematoxylin-eosin and with CD34, S-100, anti-human muscle actin, smooth muscle actin and desmin using immunohistochemistry. Survival analyses were performed using Kaplan-Meier method and log-rank test was used to determine the prognostic factors. Results: There were nine male and six female patients. Stomach was the most common site of localization (n=5). Median tumor size was 15 cm and 67% were larger than 10 cm. Five patients had disease spread beyond the site of origin. Twelve patients had complete resection. Five patients were alive after a mean follow-up of 49 months (range 18-78), two with distant metastases. Univariate analyses revealed that only tumors confined to the site of origin at presentation resulted in prolonged overall survival (p=0.01). Similarly, in completely resected patients, only extent of original tumor spread significantly affected disease-free survival (p=0.001). Conclusion: In conclusion, until more effective adjuvant therapeutic modalities become available, complete removal of malignant gastrointestinal stromal tumors with adjacent organs, if necessary, achieving negative surgical margins remains to be the only chance for cure.

Özet

Amaç: Gastrointestinal stromal tümörler sindirim sisteminin, asıl olarak içi boş organlarının mezenşimal dokularından köken alan nadir tümörleridir. Bu çalışmada, malign gastrointestinal stromal tümörü olan hastalarda prognozu etkileyen klinik ve patolojik parametrelerin saptanması amaçlanmıştır. Gereç ve Yöntem: Malign gastrointestinal stromal tümör tanısıyla 1995-2001 yılları arasında tedavi edilen hastalar retrospektif olarak incelendi. Histolojik kesitler hematoksilen eozin ile boyandı ve immünohistokimya incelemesi için CD34, S-100, anti-insan kası aktini, düz kas aktini ve desmin kullanıldı. Sağkalım analizleri Kaplan-Meier yöntemi ile prognostik faktörlerin belirlenmesi log-rank testi ile yapıldı. Bulgular: Dokuz erkek ve altı kadın hasta çalışmaya alındı. Mide, tümörün en sık yerleşim yeriydi (n=5). Ortanca tümör boyutu 15 cm'di ve tümörlerin %67'si 10 cm'den büyüktü. Beş hastada tümör köken aldığı organın dışına yayılmıştı. Oniki hastada tam rezeksiyon yapılabildi. Beş hasta ortalama 49 aylık (18-78) takip sonunda sağdı ve ikisinde uzak metastaz mevcuttu. Tek değişkenli analizde sadece başlangıçta köken aldıkları organ dışına yayılmayan tümörlerin sağkalımı uzattığı belirlendi (p=0.01). Benzer şekilde, tam rezeksiyon uygulanan hastalarda sadece başlangıçtaki tümör yayılımının hastalıksız sağkalımı etkilediği saptandı (p=0.001). Sonuç: Sonuç olarak, daha etkin adjuvan tedavi yöntemleri bulunana kadar tümörün gerekirse komşu organlarla birlikte negatif cerrahi elde edecek şekilde tam olarak çıkartılması kür için tek olasılıktır.

🔖

Cite This Article

ATALAY, C., MARKOÇ, F., PAK, I., ALTINOK, M. (2003). Gastrointestinal stromal tumors. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 3, 295–300. https://ajindex.com/articles/278526

References (14)

  1. Sircar K, Hewlet BR, Huizinga JD, Chomeyko K, Berezin I, II RH. Interstitial cells of Cajal as precursors of gastrointes-tromal tumors. Am J Surg Pathol 1999; 23:377-89.
  2. Torihashi S, Ward SM, Nishikawa SI, Nishi K, Kobayashi Sanders KM. c-kit-Dependent development of interstitial cells lectrical activity in the murine gastrointestinal tract. Cell 3 Res 1995; 280:97-111.
  3. Burns AJ, Herbert TM, Ward SM, Sanders KM. Interstitial cell of Cajal in the guinea-pig gastrointestinal tract as revealed by c-Kit immunohistochemistry. Cell Tissue Res 1997; 290:11-20.
  4. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in Tientum and mesentery. Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999; 23:1109-18.
  5. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal al tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30:1213-20.
  6. Amin MB, Ma CK, Linden MB, Kubus JJ, Zarbo RJ. prognostic value of proliferating cell nuclear antigen index in c stromal tumors. Correlation with mitotic count and clinical autcome. Am J Clin Pathol 1993; 100:428-32.
  7. McGrath PC, Neifeld JP, Lawrence W, Kay S, Horsley JS, parker GA. Gastrointestinal sarcomas. Analysis of prognostic factors. Ann Surg 1987; 206:706-10.
  8. Licht JD, Weismann LB, Antman K. Gastrointestinal sar­comas. Sem Oncol 1988; 15:181-8.
  9. Cooper PN, Quirke P, Hardy GJ, Dixon MF. A flow cytometric,clinical, and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 1992; 16:163-70.
  10. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors. Re­currence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-8.
  11. Grant CS, Kim CH, Farrugia G, Zinsmeister A, Goellner JR. Gastric leiomyosarcoma. Prognostic factors and surgical mana­ gement. Arch Surg 1991; 126:985-90. Miettinen M. Gastrointestinal stromal tumors. An immunohis- tochemical study of cellular differentiation. Am J Clin Pathol 1988; 89:601-10.
  12. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A cli­ nicopathologic and immunohistochemical study of gastrointes­ tinal stromal tumors. Cancer 1992; 69:947-55.
  13. Roy M, Sommers SC. Metastatic potential of gastric leiomyosarcoma. Path Res Pract 1989; 185:874-7.
  14. Emory TS, Sobin LH, Lukes L, Lee DH, O'leary TJ. Prog­ nosis of gastrointestinal smooth-muscle (stromal) tumors. De­ pendence on anatomic site. Am J Surg Pathol